Pain in human immunodeficiency virus (HIV) frequently co-occurs with substance use and depression. The complex associations among patient characteristics, pain, depression, and drug use in HIV suggests a role for testing models that can account for relationships simultaneously, control for HIV status, and also test for mediation. Using structural equation modeling, the current study examined associations among pain, sociodemographics, illicit drug use, and depressive symptoms in 921 HIV-seropositive and 1019 HIV-seronegative men from the Multicenter AIDS Cohort Study, an ongoing prospective study of the natural history of HIV infection among gay/bisexual men. Longitudinal repeated measures data collected over a 6-year period were analyzed using predictive path models in which sociodemographics, HIV status, and CD4+ cell counts predicted pain, which, in turn, predicted depressive symptoms and illicit drug use. The path models did not differ substantially between HIV-seropositive and -seronegative men. Analyses using the total sample indicated that pain served both as a mediator and as a predictor of more use of cannabis, cocaine, and heroin, as well as more depressive symptoms. HIV-seropositive status predicted more use of inhaled nitrites. In this cohort, having lower CD4+ cell counts (predicted by HIV status), being African American, less educated, and older were all associated with more pain, which, in turn, was associated with more illicit drug use and more depressive symptoms. The results underscore the need for adequate pain management, particularly among vulnerable subgroups of HIVseropositive and HIV-seronegative men to reduce the risk of drug use and depression. Ó
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Introduction
Pain is a common occurrence among persons living with human immunodeficiency virus (HIV)-67% of a nationally representative sample of HIV-seropositive persons in the United States reported experiencing pain in the past month [16] . Investigation of the correlates of pain in HIV has highlighted the frequent co-occurrence of pain with both psychological problems and illicit drug use [17, 18, 55] . Pain in HIV-seropositive persons is exacerbated when there is a coexisting psychological disorder [22, 47, 52, 57] , particularly depression [22, 32, 33] . Injection drug use (IDU) [15, 23, 37, 60] , as well as use of other illicit drugs (not just IDU), has also been associated with increased pain in HIV [58] . Efforts to identify which patients are more vulnerable to pain as well as depression and substance use have indicated some common clinical and sociodemographic characteristics. For example, more advanced HIV disease has been associated with both increased pain [2, 7, 8, 16, 22, 28, 50, 51] and higher rates of depression (eg, [21,38] ). Similarly, lower socioeconomic status (SES) has been linked with more pain [41, 58] and also with increased illicit drug use [58] in HIV-seropositive persons.
These findings suggest that the observed relationships among clinical/sociodemographic characteristics, pain, depression, and drug use in HIV may be part of a more complex sequence of effects. Yet, previous research has rarely employed models that go beyond simple correlational designs. The goal of a mediational model is to clarify the mechanism through which an initial variable (eg, SES) affects an outcome (eg, drug use) via a third explanatory or mediator variable [36] . We propose a conceptual model in which pain acts as a mediator between clinical/sociodemographic characteris- 
